Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Apolipoprotein E4 and memory decline in the elderly].

C Jonker1, M G Dik, G J van Kamp

  • 1Vrije Universiteit, afdeling Psychiatrie, Amsterdam. c.jonker.emgo@med.vu.nl

Tijdschrift Voor Gerontologie En Geriatrie
|November 7, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Community-based TB testing as an essential part of TB recovery plans in the COVID-19 era.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2021
Same author

Hypertension as a predictor of advanced colorectal cancer outcome and cetuximab treatment response.

Current oncology (Toronto, Ont.)·2019
Same author

[The importance of neuropsychological assessment for forensic psychiatric evaluations of defendants].

Tijdschrift voor psychiatrie·2016
Same author

Knowledge, attitudes and practices towards blood donation in Barbados.

Transfusion medicine (Oxford, England)·2016
Same author

Reciprocating instruments in endodontics: a review of the literature.

SADJ : journal of the South African Dental Association = tydskrif van die Suid-Afrikaanse Tandheelkundige Vereniging·2015
Same author

Relation between blood pressure and mortality risk in an older population: role of chronological and biological age.

Journal of internal medicine·2014
Same journal

Tijdschrift voor gerontologie en geriatrie·2026
Same journal

[Peer-advice for aging in place: An exploratory study on the perspectives of community-dwelling older adults].

Tijdschrift voor gerontologie en geriatrie·2026
Same journal

[The Clinical Applicability of Blood Biomarkers for Alzheimer's disease in the Memory Clinic].

Tijdschrift voor gerontologie en geriatrie·2026
Same journal

[Geriatric rehabilitation on Curacao].

Tijdschrift voor gerontologie en geriatrie·2025
Same journal

[Usability of activity trackers in geriatric rehabilitation].

Tijdschrift voor gerontologie en geriatrie·2025
Same journal

[Frontotemporal dementia in the elderly: Practical tools].

Tijdschrift voor gerontologie en geriatrie·2025
See all related articles

The Apolipoprotein E4 (ApoE4) gene variant increases memory decline risk in older adults with cognitive impairment. This risk persists with age, unlike findings in Alzheimer's disease studies.

Area of Science:

  • Neuroscience
  • Genetics
  • Gerontology

Context:

  • The Apolipoprotein E4 (ApoE4) genotype is a known risk factor for cognitive decline and Alzheimer's disease.
  • Understanding how ApoE4 influences memory decline in aging populations, particularly concerning baseline cognitive status and age, is crucial for targeted interventions.

Purpose:

  • To investigate the interaction between Apolipoprotein E4 (ApoE4) status, baseline cognitive impairment, and age on memory decline in a population-based elderly sample.
  • To determine if the association between ApoE4 and memory decline is modified by general cognitive status (assessed by MMSE) and age.

Summary:

  • This study analyzed 1,243 elderly participants (62-85 years) from the Longitudinal Aging Study Amsterdam (LASA) with MMSE scores between 21-30.
  • Memory performance was assessed using the Auditory Verbal Learning Test (AVLT) at baseline and after three years. Memory decline was defined as a significant decrease in recall scores.

Related Experiment Videos

  • ApoE4 was significantly associated with memory decline in subjects with baseline cognitive impairment (MMSE 21-26), but not in those cognitively normal (MMSE 27-30). Notably, cognitively impaired E4 carriers over 75 showed a high risk of memory decline, suggesting ApoE4's risk does not diminish with age.

    • Impact:

    • Findings indicate that baseline cognitive status is a critical moderator of the ApoE4 genotype's effect on memory decline.
    • The study highlights that the risk associated with ApoE4 for memory decline does not decrease with advancing age, contrary to some Alzheimer's disease research.
    • This research provides valuable insights for identifying at-risk elderly individuals and developing age-specific, cognitively-tailored prevention strategies.